½ÃÀ庸°í¼­
»óǰÄÚµå
1608930

¼¼°èÀÇ ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå : ¸ð´Þ¸®Æ¼, Ä¡·á ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Liquid Medical Oxygen Market by Modality (Portable Oxygen System, Stationary/Standalone Oxygen System), Treatment Application (Carbon Monoxide Poisoning, Heart Attacks, High Fevers), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾×ü ÀÇ·á »ê¼Ò ½ÃÀåÀº 2023³â¿¡ 89¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 95¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.26%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 167¾ï 2,000¸¸ ´Þ·¯°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾×ü ÀÇ·á »ê¼Ò(LMO)´Â ÀÇ·á¿¡¼­ Áß¿äÇÑ ±¸¼º¿ä¼ÒÀ̸ç, ÁַΠȣÈí ¿ä¹ý, ¼ö¼ú, ÁýÁß Ä¡·á½Ç¿¡¼­ »ç¿ëµÇ¸ç ½É°¢ÇÑ °æ¿ì¿¡µµ ȯÀÚÀÇ »ýÁ¸À» º¸ÀåÇÕ´Ï´Ù. ±× ¼ö¿ä´Â COVID-19ÀÇ ´ëÀ¯Çà½Ã ±ÞÁõÇϰí È£Èí±â ½Ã½ºÅÛÀÇ ¹®Á¦ ¹× ±âŸ ÀÇ·á ±ä±Þ »çŸ¦ °ü¸®ÇÒ Çʿ伺ÀÌ ºÎ°¢µÇ¾ú½À´Ï´Ù. LMOÀÇ Á᫐ ¿ëµµ´Â »ê¼Ò ¿ä¹ý¿¡ ÀÖÀ¸¸ç ¸¸¼º Æó»ö¼º Æó Áúȯ(COPD), Àú»ê¼ÒÁõ, ´Ù¾çÇÑ ½ÉÆó Àå¾Ö¿Í °°Àº Áõ»óÀ» µ½½À´Ï´Ù. ÀÌ ³ôÀº ¼ö¿ä´Â º´¿ø, Ŭ¸®´Ð, ÀÀ±Þ ÀÇ·á ¼¾ÅÍ ¹× ÀçÅÃÄ¡·á¿¡¼­ÀÇ ÃÖÁ¾ ¿ëµµ¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. LMO ½ÃÀåÀº Àα¸ °í·ÉÈ­, È£Èí±â Áúȯ À¯º´·ü Áõ°¡, ÀçÅÃÄ¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. °Ô´Ù°¡ È¿°úÀûÀÎ ÀúÀ塤À¯Åë ½Ã½ºÅÛ µîÀÇ ±â¼úÀû Áøº¸¿Í Á¤ºÎÀÇ ÀÇ·á ±¸»óÀÌ ÇÔ²² ½ÃÀåÀÇ ¼ºÀå ÀáÀç·ÂÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀåÀº ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, Áö¹æÀÇ ¹°·ù °úÁ¦, »ý»ê ¹× ÀúÀå ÀÎÇÁ¶óÀÇ ³ôÀº ºñ¿ë°ú °°Àº °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¼øµµ ¼öÁØÀÇ Çâ»ó, Áõ¹ß ¼Õ½ÇÀ» ÁÙÀ̱â À§ÇÑ ¿ë±â ±â¼úÀÇ °³¼±, »ý»ê¿¡ À־ÀÇ Ä£È¯°æ ¿¡³ÊÁö¿øÀÇ Ã¤¿ë µî, ±âȸ´Â dzºÎÇÏ°Ô ÀÖ½À´Ï´Ù. ÃÖ÷´Ü ±â¼ú¿¡ ÅõÀÚÇÏ¿© ³ôÀº ¿î¿µ ºñ¿ëÀ» »ó¼âÇÔÀ¸·Î½á »õ·Î¿î ½ÃÀåÀÇ ±æÀ» ´õ¿í ¿­ ¼ö ÀÖ½À´Ï´Ù. ¼ÒÇü ÈÞ´ë¿ë »ê¼Ò ½Ã½ºÅÛ°ú ½º¸¶Æ® »ê¼Ò °ø±Þ ÀåÄ¡ÀÇ Çõ½ÅÀº È®Àå¿¡ ´ëÇÑ ¹Ì°³Ã´ °¡´É¼ºÀ» º¸¿©ÁÝ´Ï´Ù. ÀÌÁ¡À» ¾òÀ¸·Á¸é ÀÌÇØ°ü°èÀÚ´Â »ý»ê È¿À²¼º ÃÖÀûÈ­ ¹× ¿î¼Û ºñ¿ë Àý°¨¿¡ °üÇÑ Á¶»ç¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. ¼ºÀåÀÇ ¶Ç ´Ù¸¥ ¹æ¹ýÀº Á÷Á¢ °ø±Þ °è¾àÀ»À§ÇÑ º´¿ø°úÀÇ Á¦ÈÞ¿Í ¼ö¿ä¸¦ °£¼ÒÈ­Çϰí ȯÀÚÀÇ °á°ú¸¦ °³¼± ÇÒ ¼öÀÖ´Â ¿ø°Ý ÀÇ·á Áøº¸¿¡ ÀÖ½À´Ï´Ù. °Ô´Ù°¡ Áö¼Ó °¡´ÉÇÑ Á¶´Þ°ú »ý»êÀ» ¸ð»öÇÔÀ¸·Î½á ȯ°æ ¿ì·Á¿¡ ´ëóÇÒ ¼ö Àֱ⠶§¹®¿¡ ȯ°æ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ºñÁî´Ï½º¸¦ À¯¸®ÇÏ°Ô ÀÚ¸® ÀâÀ» ¼ö ÀÖ½À´Ï´Ù. LMO ½ÃÀåÀº °øÁߺ¸°Ç µ¿Çâ°ú ½ÃÃ¥¿¡ º»ÁúÀûÀ¸·Î ÀÇÁ¸Çϰí ÀÖÀ¸¸ç, ±ÔÁ¦ÀÇ º¯È­¿Í ÀÇ·á ¼ö¿ä¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÀûÀÀÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 89¾ï 9,000¸¸ ´Þ·¯
ÃßÁ¤³â (2024³â) 95¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 167¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 9.26%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾×ü ÀÇ·á »ê¼Ò ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾×ü ÀÇ·á »ê¼Ò ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù., »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º È£Èí±â ÁúȯÀÌ ¸¸¿¬
    • °¢±¹¿¡¼­ÀÇ °í·ÉÈ­ Àα¸ Áõ°¡
    • ÀÇ·á »ê¾÷¿¡ À־ÀÇ °í¼øµµ »ê¼Ò¿øÀÇ ¼±È£
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¾×ü ÀÇ·á »ê¼ÒÀÇ À̿밡´É¼º ¹× °ø±ÞÀÇ Á¦ÇÑ
  • ½ÃÀå ±âȸ
    • ÀÇ·á½Ã¼³¿¡ ´ëÇÑ ÅõÀÚ¿Í ½Ã¼³¼ö Áõ°¡
    • ÈÞ´ë¿ë ¾×ü »ê¼Ò µð¹ÙÀ̽ºÀÇ ÀÌ¿ë È®´ë
  • ½ÃÀåÀÇ °úÁ¦
    • ¾×ü ÀÇ·á »ê¼ÒÀÇ Æ¯¼öÇÑ º¸°ü¡¤Ãë±Þ ¿ä°Ç

Porter's Five Force : ¾×ü ÀÇ·á »ê¼Ò ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¸°ÔÇÏ¸é ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾×ü ÀÇ·á »ê¼Ò ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹ÃøÇÒ ¼ö ÀÖ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾ú½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

¾×ü ÀÇ·á »ê¼Ò ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁß, ºÎ¹®È­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­µÇ´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Âµ¥ ÇÊ¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¾×ü ÀÇ·á »ê¼Ò ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º È£Èí±â ÁúȯÀÇ À¯º´·üÀÌ ³ô´Ù
      • °¢±¹¿¡¼­ °í·ÉÈ­°¡ ÁøÇàµÈ´Ù
      • ÀÇ·á »ê¾÷À¸·ÎºÎÅÍÀÇ °í¼øµµ »ê¼Ò¿øÀÇ ¿ì¼±
    • ¾ïÁ¦¿äÀÎ
      • ¾×ü ÀÇ·á »ê¼ÒÀÇ Àç°í¿Í °ø±ÞÀÌ ÇÑÁ¤µÇ¾î ÀÖ´Ù
    • ±âȸ
      • ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ ÅõÀÚ¿Í ¼ö Áõ°¡
      • ÈÞ´ëÇü ¾×ü »ê¼Ò ÀåÄ¡ÀÇ »õ·Î¿î ÀÌ¿ë
    • °úÁ¦
      • ¾×ü ÀÇ·á »ê¼ÒÀÇ Æ¯Á¤ º¸°ü ¹× Ãë±Þ ¿ä°Ç
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ¼Ò°³
  • ÈÞ´ë¿ë »ê¼Ò ½Ã½ºÅÛ
  • °ÅÄ¡Çü/µ¶¸³Çü »ê¼Ò ½Ã½ºÅÛ

Á¦7Àå ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå : Ä¡·á ¿ëµµº°

  • ¼Ò°³
  • ÀÏ»êȭź¼Ò Áßµ¶
  • ½ÉÀå ¹ßÀÛ
  • °í¿­
  • Æó¿Í ½ÉÀåÀÇ Áúº´
  • ±³Åë»ç°í
  • ½ÉÇÑ ½ÇÇ÷

Á¦8Àå ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ÀÀ±Þ ÀÇ·á ¼¾ÅÍ
  • ÀçÅÃÄ¡·á
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾×ü ÀÇ·á »ê¼Ò ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Air Products and Chemicals, Inc.
  • Airgas, Inc.
  • Atlas Copco
  • GCE Group AB
  • INOX-Air Products Inc.
  • Les Gaz Industriels Ltd.
  • Linde PLC
  • Matheson Tri-Gas, Inc.
  • Messer Group GmbH
  • National Gases Limited
  • Organa International
  • Purity Cylinder Gases, Inc.
  • SOL Group
  • TAIYO NIPPON SANSO CORPORATION
JHS 24.12.20

The Liquid Medical Oxygen Market was valued at USD 8.99 billion in 2023, expected to reach USD 9.52 billion in 2024, and is projected to grow at a CAGR of 9.26%, to USD 16.72 billion by 2030.

Liquid medical oxygen (LMO) is a critical component in healthcare, primarily used in respiratory therapy, surgeries, and intensive care units, ensuring patient survival in critical cases. Its demand surged during the COVID-19 pandemic, highlighting its necessity when managing respiratory issues and other medical emergencies. LMO's core application lies in oxygen therapy, aiding conditions like chronic obstructive pulmonary disease (COPD), hypoxia, and various cardiopulmonary disorders. This high demand pushes its end-use in hospitals, clinics, emergency medical centers, and home healthcare settings. The LMO market is driven by an aging population, increasing prevalence of respiratory ailments, and the escalating demand for home healthcare solutions. Furthermore, technological advancements like effective storage and distribution systems, coupled with government healthcare initiatives, amplify the market's growth potential. However, the market faces challenges like stringent regulatory frameworks, logistical challenges in rural areas, and the high cost of production and storage infrastructure. Opportunities abound in enhancing purity levels, improving container technology to reduce evaporation loss, and employing eco-friendly energy sources in production. Offsetting the high operational costs by investing in cutting-edge technologies can further open new market avenues. Innovations in smaller, portable oxygen systems and smart oxygen delivery devices present untapped potential for expansion. To excel, stakeholders should focus on research in optimizing production efficiency and reducing transportation costs. Another avenue for growth lies in partnerships with hospitals for direct supply contracts and advancements in telemedicine, which can streamline demand and deliver better patient outcomes. Moreover, exploring sustainable sourcing and production can address environmental concerns, thus positioning businesses favorably amid growing ecological awareness. The LMO market remains intrinsically dependent on public health trends and policies, demanding continuous adaptation to regulatory changes and healthcare demands.

KEY MARKET STATISTICS
Base Year [2023] USD 8.99 billion
Estimated Year [2024] USD 9.52 billion
Forecast Year [2030] USD 16.72 billion
CAGR (%) 9.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Liquid Medical Oxygen Market

The Liquid Medical Oxygen Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of chronic respiratory diseases
    • Increasing aging population across countries
    • Preference for high purity oxygen sources from medical industry
  • Market Restraints
    • Limited availability and supply of liquid medical oxygen
  • Market Opportunities
    • Increasing investment and the number of healthcare facilities
    • Emerging use of portable liquid oxygen devices
  • Market Challenges
    • Specific storage and handling requirements of liquid medical oxygen

Porter's Five Forces: A Strategic Tool for Navigating the Liquid Medical Oxygen Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Liquid Medical Oxygen Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Liquid Medical Oxygen Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Liquid Medical Oxygen Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Liquid Medical Oxygen Market

A detailed market share analysis in the Liquid Medical Oxygen Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Liquid Medical Oxygen Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Liquid Medical Oxygen Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Liquid Medical Oxygen Market

A strategic analysis of the Liquid Medical Oxygen Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Liquid Medical Oxygen Market, highlighting leading vendors and their innovative profiles. These include Air Products and Chemicals, Inc., Airgas, Inc., Atlas Copco, GCE Group AB, INOX-Air Products Inc., Les Gaz Industriels Ltd., Linde PLC, Matheson Tri-Gas, Inc., Messer Group GmbH, National Gases Limited, Organa International, Purity Cylinder Gases, Inc., SOL Group, and TAIYO NIPPON SANSO CORPORATION.

Market Segmentation & Coverage

This research report categorizes the Liquid Medical Oxygen Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Modality, market is studied across Portable Oxygen System and Stationary/Standalone Oxygen System.
  • Based on Treatment Application, market is studied across Carbon Monoxide Poisoning, Heart Attacks, High Fevers, Lung & Heart Conditions, Road Traffic Accident, and Severe Blood Loss.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Emergency Medical Centers, Home Care Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of chronic respiratory diseases
      • 5.1.1.2. Increasing aging population across countries
      • 5.1.1.3. Preference for high purity oxygen sources from medical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and supply of liquid medical oxygen
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment and the number of healthcare facilities
      • 5.1.3.2. Emerging use of portable liquid oxygen devices
    • 5.1.4. Challenges
      • 5.1.4.1. Specific storage and handling requirements of liquid medical oxygen
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Liquid Medical Oxygen Market, by Modality

  • 6.1. Introduction
  • 6.2. Portable Oxygen System
  • 6.3. Stationary/Standalone Oxygen System

7. Liquid Medical Oxygen Market, by Treatment Application

  • 7.1. Introduction
  • 7.2. Carbon Monoxide Poisoning
  • 7.3. Heart Attacks
  • 7.4. High Fevers
  • 7.5. Lung & Heart Conditions
  • 7.6. Road Traffic Accident
  • 7.7. Severe Blood Loss

8. Liquid Medical Oxygen Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Emergency Medical Centers
  • 8.4. Home Care Settings
  • 8.5. Hospitals

9. Americas Liquid Medical Oxygen Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Liquid Medical Oxygen Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Liquid Medical Oxygen Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Air Products and Chemicals, Inc.
  • 2. Airgas, Inc.
  • 3. Atlas Copco
  • 4. GCE Group AB
  • 5. INOX-Air Products Inc.
  • 6. Les Gaz Industriels Ltd.
  • 7. Linde PLC
  • 8. Matheson Tri-Gas, Inc.
  • 9. Messer Group GmbH
  • 10. National Gases Limited
  • 11. Organa International
  • 12. Purity Cylinder Gases, Inc.
  • 13. SOL Group
  • 14. TAIYO NIPPON SANSO CORPORATION
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦